9-[5-[2-(2-carbazol-9-ylcarbazol-9-yl)phenyl]-2-cyanophenyl]carbazole-2-carbonitrile
C50H29N5 — CID 154958901
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[5-[2-(2-carbazol-9-ylcarbazol-9-yl)phenyl]-2-cyanophenyl]carbazole-2-carbonitrile
9-[5-[2-(2-carbazol-9-ylcarbazol-9-yl)phenyl]-2-cyanophenyl]carbazole-2-carbonitrile (PubChem CID 154958901) has the molecular formula C50H29N5 and a molecular weight of 699.82 g/mol. Its IUPAC name is 9-[5-[2-(2-carbazol-9-ylcarbazol-9-yl)phenyl]-2-cyanophenyl]carbazole-2-carbonitrile.
Molecular Properties
| Compound Name | 9-[5-[2-(2-carbazol-9-ylcarbazol-9-yl)phenyl]-2-cyanophenyl]carbazole-2-carbonitrile |
|---|---|
| PubChem CID | 154958901 |
| Molecular Formula | C50H29N5 |
| Molecular Weight | 699.82 g/mol |
| Exact Mass | 699.24 |
| IUPAC Name | 9-[5-[2-(2-carbazol-9-ylcarbazol-9-yl)phenyl]-2-cyanophenyl]carbazole-2-carbonitrile |
| SMILES | N#Cc1ccc2c3ccccc3n(-c3cc(-c4ccccc4-n4c5ccccc5c5ccc(-n6c7ccccc7c7ccccc76)cc54)ccc3C#N)c2c1 |
| InChI | InChI=1S/C50H29N5/c51-30-32-21-25-41-39-14-5-10-20-47(39)55(49(41)27-32)48-28-33(22-23-34(48)31-52)36-11-1-6-16-43(36)54-46-19-9-4-15-40(46)42-26-24-35(29-50(42)54)53-44-17-7-2-12-37(44)38-13-3-8-18-45(38)53/h1-29H |
| InChIKey | JWPNUPMZYDGGMN-UHFFFAOYSA-N |
| XLogP | 12.39 |
| TPSA | 62.37 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 699.82 |
| LogP ≤ 5 | 12.39 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154958901 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.